NN2211-4077 Retrospective collection of effectiveness and safety data from patients treated with liraglutide or DPP-4 inhibitor in primary care in Europe

27/02/2015
02/04/2024
EU PAS number:
EUPAS8135
Study
Finalised
Documents
Study protocol
Initial protocol
English (392.69 KB - PDF) View document
Study results
Study results
English (869.72 KB - PDF) View document
Study report
Other information